WASHINGTON, UNITED STATES: The US Food and Drug Administration on Friday banned several key chemicals in antibacterial hand soap, warning of health risks and saying they were not more effective than ordinary soap.
The U.S. Food and Drug Administration approved Novartis AG's injectable drug, Cosentyx, to treat adults with a moderate to severe skin disease called plaque psoriasis.